Skip to main content
. 2020 Aug 18;21:218. doi: 10.1186/s12931-020-01483-0

Table 2.

The demographics and characteristics of patients

Variables AECOPD(n = 948) AECOPD-PE(n = 210) P value
Age-years 66.9 ± 18.6 68.1 ± 20.3 0.858
Age<50-no.(%) 26(2.7) 5(2.4) 0.769
Age ≥ 50-no.(%) 922(97.3) 205(97.6)
Female-no.(%) 303(32.0) 72(34.3) 0.515
Male-no.(%) 645(68.0) 138(65.7)
Smoker-no.(%) 633(66.8) 145(69.0) 0.525
Nonsmoker-no.(%) 315(33.2) 65(31.0)
BODE index 5.9 ± 3.6 6.2 ± 3.4 0.095
D-dimer-ng/ml 1191 ± 676 3118 ± 1635 <0.001
Wells score 3.3 ± 1.4 6.5 ± 3.3 <0.001
DVT sign-no.(%) 96(10.1) 66(31.4) <0.001
No DVT sign-no.(%) 852(89.9) 144(68.6)
PE likely-no.(%) 555(58.5) 177(84.3) <0.001
PE unlikely-no.(%) 393(41.5) 33(15.7)
HR ≤ 100beats/min-no.(%) 450(47.5) 102(48.6) 0.772
HR>100beats/min-no.(%) 498(52.5) 108(51.4)
Recent immobilization-no.(%) 640(67.5) 186(88.6) <0.001
No recent immobilization-no.(%) 308(32.5) 24(11.4)
Recent surgery-no.(%) 99(10.4) 45(21.4) <0.001
No recent surgery-no.(%) 849(89.6) 165(78.6)
History of VTE 84(8.9) 21(10.0) 0.603
No history of VTE 864(91.1) 189(90.0)
Hemoptysis-no.(%) 66(7.0) 12(5.7) 0.514
No hemoptysis-no.(%) 882(93.0) 198(94.3)
Cancer-no.(%) 147(15.5) 54(25.7) <0.001
No cancer-no.(%) 801(84.5) 156(74.3)
SaO2 ≤ 94%-no.(%) 806(85.0) 188(89.5) 0.090
SaO2>94%-no.(%) 142(15.0) 22(10.5)
Oral hormone use-no.(%) 275(29.0) 78(37.1) 0.021
No oral hormone use-no.(%) 673(71.0) 132(62.9)

AECOPD Acute Exacerbation of Chronic Obstructive Pulmonary Disease, PE Pulmonary Embolism, no. number, BODE Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity, DVT Deep Venous Thrombosis, HR Heart Rate, VTE Venous Thromboembolism, SaO2 Arterial Oxygen Saturation